Literature DB >> 8873146

Increased tau immunoreactivity in oligodendrocytes following human stroke and head injury.

E A Irving1, J Nicoll, D I Graham, D Dewar.   

Abstract

Tau immunohistochemistry was performed on post-mortem brain tissue from patients who died following head injury or stroke and from neurologically normal controls. Tau-positive oligodendrocytes were detected with three different tau antibodies in head injured or stroke patients, but not in control cases. Tau-positive oligodendrocytes were detected 2 h following head injury indicating that accumulation of tau may be an acute response of these cells to brain injury. The mechanisms underlying accumulation of tau in oligodendrocytes after acute brain injury may be similar to those which occur in chronic neurodegenerative conditions such as progressive supranuclear palsy (PSP) and multi-system atrophy (MSA).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8873146     DOI: 10.1016/0304-3940(96)12856-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

Review 1.  Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

Review 2.  The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease.

Authors:  Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2007-12-04       Impact factor: 3.444

Review 3.  Glial function (and dysfunction) in the normal & ischemic brain.

Authors:  Shino D Magaki; Christopher K Williams; Harry V Vinters
Journal:  Neuropharmacology       Date:  2017-11-06       Impact factor: 5.250

Review 4.  Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies.

Authors:  J Szczygielski; A Mautes; W I Steudel; P Falkai; T A Bayer; O Wirths
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

5.  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients.

Authors:  James W Simpkins; Joshua W Gatson; Jane G Wigginton
Journal:  Alzheimers Dement       Date:  2009-03       Impact factor: 21.566

6.  Common patterns of bcl-2 family gene expression in two traumatic brain injury models.

Authors:  Kenneth I Strauss; Raj K Narayan; Ramesh Raghupathi
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

7.  Neurodegeneration and Glial Response after Acute Striatal Stroke: Histological Basis for Neuroprotective Studies.

Authors:  Rafael R Lima; Luana N S Santana; Rafael M Fernandes; Elder M Nascimento; Ana Carolina A Oliveira; Luanna M P Fernandes; Enio Mauricio N Dos Santos; Patrycy Assis N Tavares; Ijair Rogério Dos Santos; Adriano Gimarães-Santos; Walace Gomes-Leal
Journal:  Oxid Med Cell Longev       Date:  2016-12-05       Impact factor: 6.543

Review 8.  Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America.

Authors:  Gloria Patricia Cardona-Gómez; Francisco Lopera
Journal:  Front Aging Neurosci       Date:  2016-12-20       Impact factor: 5.750

9.  Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke.

Authors:  Clara Hjalmarsson; Maria Bjerke; Björn Andersson; Kaj Blennow; Henrik Zetterberg; N David Aberg; Bob Olsson; Carl Eckerström; Lena Bokemark; Anders Wallin
Journal:  J Cent Nerv Syst Dis       Date:  2014-05-19

10.  Ameliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain Injury.

Authors:  Xiaoping Du; Matthew B West; Weihua Cheng; Donald L Ewert; Wei Li; Debra Saunders; Rheal A Towner; Robert A Floyd; Richard D Kopke
Journal:  Oxid Med Cell Longev       Date:  2015-12-16       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.